MS Patient's Pick of the Week's News: Ocrevus and Its Approval, Reactions, Development - Multiple Sclerosis News Today

KRDO

MS Patient's Pick of the Week's News: Ocrevus and Its Approval, Reactions, Development Multiple Sclerosis News Today Today, my Pick of the Week's News is devoted to various news stories, all published by Multiple Sclerosis News Today, about FDA approval of Genentech's Ocrevus as an MS treatment. FDA Approves Ocrevus as 1st MS Treatment for Both Relapsing and ... When $65000 a year for a drug is applaudedKRDO FDA Approves First Major Drug to Treat Primary Progressive MSCare2.com New Treatment for Multiple Sclerosisfox15abilene.com Bel Marra Health all 6 news articles »

from Health - Google News http://ift.tt/2nwQ0OI